PPH Fees and Costs — VanEck Pharmaceutical ETF
Data updated: 2026-08-26
The net expense ratio is 0.36%: a 0.35% management fee plus 0.01% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $101K in broker commissions, 0.0167% of average net assets, and portfolio turnover was 30%.
PPH Fees and Expenses
Annual operating expenses and sales charges of PPH. Prospectus, as of February 1, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.35% |
| 12b-1 fee | — |
| Other expenses | 0.01% |
| Gross expense ratio | 0.36% |
| Fee waiver | — |
| Net expense ratio | 0.36% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
PPH Costs Over Time
On $10,000 invested in PPH, assuming 5% a year before costs, total costs come to $239 over 5 years, cutting the return by 0.40% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.36%) | $38 | $119 | $207 |
| Trading costs (broker commissions) | $2 | $6 | $10 |
| Lost growth on money paid in costs | $0 | $6 | $22 |
| Total costs | $40 | $130 | $239 |
| Value after costs | $10,460 | $11,446 | $12,524 |
| Impact on return, per year | 0.40% | 0.40% | 0.40% |
PPH Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0167%
- Total broker commissions: $101K
- Bought from dealers (principal trades, not a cost): $3.7B
- Portfolio turnover (prospectus): 30%
- Securities on loan, average value: $71.5M
- Net income from securities lending: $222K (0.037% of average net assets)
PPH Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BofA Securities, Inc. | $39K | 38.40% |
| Citigroup Global Markets Inc. | $32K | 31.84% |
| Goldman Sachs & Co. LLC | $17K | 17.30% |
| Morgan Stanley & Co. LLC | $12K | 11.51% |
| Robert W. Baird & Co. Incorporated | $963 | 0.95% |
PPH Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| National Securities Clearing Corporation | $3.7B | 100.00% |
| Citigroup Global Markets Inc. | $13 | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.